Biliary atresia is a rare disease of infancy, which has changed within 30 years from being
fatal to being a disorder for which effective palliative surgery or curative liver transplantation …

Biliary atresia presents as an obliterative cholangiopathy with neonatal jaundice and pale
stools. The disease exhibits aetiological heterogeneity with a multiplicity of potential …

Biliary atresia is a severe cholangiopathy of early infancy that destroys extrahepatic bile
ducts and disrupts bile flow. With a poorly defined disease pathogenesis, treatment consists …

Neonatal cholestatic disorders are a group of hepatobiliary diseases occurring within the
first 3 months of life. Bile flow is impaired, and patients have conjugated hyperbilirubinemia …

Biliary atresia (BA) is the end result of a destructive, inflammatory process that affects intra‐
and extrahepatic bile ducts, leading to fibrosis and obliteration of the biliary tract with the …

Biliary atresia is the most common cause of end‐stage liver disease in the infant and is the
leading pediatric indication for liver transplantation in the United States. Earlier diagnosis (< …

Biliary atresia (BA) is a devastating fibro-inflammatory disease characterized by the
obstruction of extrahepatic and intrahepatic bile ducts in infants that can have fatal …

Objective: The goals of this study were to describe the clinical and anatomic features of
infants undergoing Kasai portoenterostomy (KPE) for biliary atresia (BA) and to examine …

Biliary atresia (BA) is a rapidly progressive and destructive fibrotic disorder of unknown
etiology affecting the extrahepatic biliary tree of neonates. Epidemiological studies suggest …

Biliary atresia (BA) is a rare disease of unknown etiology and unpredictable outcome, even
when there has been timely diagnosis and exemplary surgery. It has been the commonest …